Ashley McCook-Veal

8PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPowder and particle technologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 21, 2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.

Nabil F Saba, Ritu Chaudhary, Kedar Kirtane

|Jul 02, 2024
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.

Nabil F Saba, Conor E Steuer, Asari Ekpenyong

|Nov 22, 2023
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer.

Rajesh M Valanparambil, Lilin Lai, Margaret A Johns

|Apr 14, 2023
Efficacy and tolerability of zinc acetate for treatment of chronic refractory cough: pilot randomised futility trial.

Aparna Balasubramanian, Janet T Holbrook, Brendan J Canning

|Apr 03, 2023
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.

Nabil F Saba, Conor E Steuer, Asari Ekpenyong

|Jun 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.

Rajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman

Pageof 2

Frequent Collaborators

3 joint publications

Andres Chang

3 joint publications

Akil Akthar

3 joint publications

Christine H Chung

3 joint publications

William Stokes